| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 35.00M | — |
| Operating expense | — | — |
| Net income | 27.90M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ATNM returned -39.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -22.8% |
| 1 year | -39.7% |
| 5 years | -82.7% |
| 10 years | -98.1% |
| All-time high | $373.50 (Mar 2014) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ATNM would be worth today ›No. Actinium Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Actinium Pharmaceuticals, Inc. stock trades on NYSEAMERICAN under the ticker symbol ATNM.
Actinium Pharmaceuticals, Inc. is part of the Healthcare sector.
Actinium Pharmaceuticals, Inc. has a market cap of 32.94M USD, based on the latest quote.